Pancreatic Cancer Treatment: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Pancreatic Cancer Treatment

Pancreatic Cancer Treatment represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Pancreatic Cancer Treatment Recommended?

• Newly diagnosed pancreatic ductal adenocarcinoma (resectable, borderline resectable, locally advanced, or metastatic).

• Borderline resectable pancreatic tumors requiring neoadjuvant modified FOLFIRINOX downstaging.

• BRCA-mutated metastatic pancreatic cancer eligible for Olaparib PARP maintenance therapy.

• Unexplained jaundice, severe epigastric/back pain, weight loss, or new-onset diabetes in older adults.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Pancreatic Protocol CT & EUS

Pancreatic-protocol contrast CT, EUS with fine-needle biopsy (FNB), and serum CA 19-9 kinetics.

Step 2: Molecular & Vascular Review

Germline BRCA1/2, PALB2 genetic testing, and multidisciplinary tumor board surgical resectability review.

Step 3: Intensive Systemic Chemotherapy

Administration of modified FOLFIRINOX or Gemcitabine + Nab-Paclitaxel in Day Care suite.

Step 4: Surgical Resection & Follow-Up

Curative Whipple resection followed by post-op adjuvant therapy and long-term surveillance.

Director's Signature Innovation: Comprehensive Multimodal Pancreatic Cancer Treatment

Dr. Neha Gupta coordinates multidisciplinary Pancreatic Oncology for pancreatic ductal adenocarcinoma (PDAC). Utilizing multi-agent intensive regimens (modified FOLFIRINOX or Gemcitabine + Nab-Paclitaxel) in neoadjuvant settings, borderline resectable tumors involving the superior mesenteric vein/artery are downstaged to enable curative Whipple pancreaticoduodenectomy (R0 resection). Furthermore, upfront germline BRCA testing enables targeted PARP inhibitor maintenance (Olaparib - POLO protocol) to sustain long-term disease remission.

✔ Modified FOLFIRINOX Protocol: Triples median overall survival compared to historical single-agent therapy

✔ Borderline Resectable Downstaging: Converts locally advanced vascular-involved tumors into surgical cures

✔ Germline BRCA & KRAS Testing: Molecular profiling guiding Olaparib maintenance and targeted clinical therapies

✔ Pancreatic Enzyme Replacement Therapy (PERT): Optimized digestion and nutrition preventing weight loss

Recovery Timeline & Functional Milestones

Phase 1: Diagnostic Staging & Biliary Clearance (Day 1 – 7)

Triple-phase pancreatic protocol CT, EUS-guided FNA biopsy, serum CA 19-9, and biliary stenting if jaundiced.

Phase 2: Neoadjuvant Chemotherapy Phase (Month 1 – 3)

Neoadjuvant modified FOLFIRINOX (4–6 cycles) in Daycare suite with intensive nutritional support.

Phase 3: Curative Surgical Resection (Month 4 – 5)

Whipple pancreaticoduodenectomy or distal pancreatectomy followed by surgical recovery.

Phase 4: Adjuvant Completion & Surveillance (Month 6 – Long Term)

Adjuvant chemotherapy completion, PERT enzyme optimization, and serial CA 19-9 / CT surveillance.

Frequently Asked Clinical Questions (FAQs)

What is FOLFIRINOX chemotherapy for pancreatic cancer?

FOLFIRINOX is a powerful combination of 4 chemotherapy drugs (5-FU, Leucovorin, Irinotecan, Oxaliplatin). In modern pancreatic cancer care, it has substantially increased survival and can shrink border-line tumors that were initially considered inoperable so they can be safely removed by surgery.

What is a Whipple surgery for pancreatic cancer?

A Whipple procedure (pancreaticoduodenectomy) is a specialized surgical operation to remove the head of the pancreas, duodenum, gallbladder, and bile duct. It is the only potentially curative surgical option for tumors located in the head of the pancreas.

Is Pancreatic Cancer Treatment cashless under Ayushman Bharat?

Yes, pancreatic cancer surgeries, Whipple procedures, FOLFIRINOX chemotherapy, enzyme replacements, and ICU care at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Pancreatic Cancer Treatment is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.